NCT04249336View on ClinicalTrials.gov

Clinical Efficacy Of BioMin F, Colgate Sensitive Pro-Relief And Sensodyne Rapid Action Dentifrices In DH

PHASE3CompletedINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

September 27, 2019

Primary Completion Date

January 16, 2021

Study Completion Date

January 16, 2021

Conditions

Dentin Hypersensitivity

Interventions

DRUG

Fluoro-Calcium-Phospho-Silicate based dentifrices

Bio-Active glass based formulation

DRUG

8% Arginine based dentifrices

Tubular occluding formulation

DRUG

8% Strontium Acetate

Tubular occluding formulation

DRUG

Sodium Fluoride

No claim of relieving Dentin Hypersensitivity

Trial Locations (1)

74600

Dr Syed Jaffar Abbas Zaidi, Karachi

All Listed Sponsors

lead

Dow University of Health Sciences

OTHER

NCT04249336 - Clinical Efficacy Of BioMin F, Colgate Sensitive Pro-Relief And Sensodyne Rapid Action Dentifrices In DH | Biotech Hunter | Biotech Hunter